527 related articles for article (PubMed ID: 32818467)
1. IL4I1 Is a Metabolic Immune Checkpoint that Activates the AHR and Promotes Tumor Progression.
Sadik A; Somarribas Patterson LF; Öztürk S; Mohapatra SR; Panitz V; Secker PF; Pfänder P; Loth S; Salem H; Prentzell MT; Berdel B; Iskar M; Faessler E; Reuter F; Kirst I; Kalter V; Foerster KI; Jäger E; Guevara CR; Sobeh M; Hielscher T; Poschet G; Reinhardt A; Hassel JC; Zapatka M; Hahn U; von Deimling A; Hopf C; Schlichting R; Escher BI; Burhenne J; Haefeli WE; Ishaque N; Böhme A; Schäuble S; Thedieck K; Trump S; Seiffert M; Opitz CA
Cell; 2020 Sep; 182(5):1252-1270.e34. PubMed ID: 32818467
[TBL] [Abstract][Full Text] [Related]
2. Indoleamine 2, 3-Dioxygenase 1 Mediates Survival Signals in Chronic Lymphocytic Leukemia
Atene CG; Fiorcari S; Mesini N; Alboni S; Martinelli S; Maccaferri M; Leonardi G; Potenza L; Luppi M; Maffei R; Marasca R
Front Immunol; 2022; 13():832263. PubMed ID: 35371054
[TBL] [Abstract][Full Text] [Related]
3. Human Chorionic Gonadotropin-Stimulated Interleukin-4-Induced-1 (IL4I1) Promotes Human Decidualization via Aryl Hydrocarbon Receptor.
Luo JM; Zhang TT; He YY; Luo HN; Hong YQ; Yang ZM
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834576
[TBL] [Abstract][Full Text] [Related]
4. IL4i1 and IDO1: Oxidases that control a tryptophan metabolic nexus in cancer.
Zeitler L; Murray PJ
J Biol Chem; 2023 Jun; 299(6):104827. PubMed ID: 37196768
[TBL] [Abstract][Full Text] [Related]
5. Endogenous Indole Pyruvate Pathway for Tryptophan Metabolism Mediated by IL4I1.
Zhang X; Gan M; Li J; Li H; Su M; Tan D; Wang S; Jia M; Zhang L; Chen G
J Agric Food Chem; 2020 Sep; 68(39):10678-10684. PubMed ID: 32866000
[TBL] [Abstract][Full Text] [Related]
6. What role for AHR activation in IL4I1-mediated immunosuppression ?
Castellano F; Prevost-Blondel A; Cohen JL; Molinier-Frenkel V
Oncoimmunology; 2021 May; 10(1):1924500. PubMed ID: 34026337
[TBL] [Abstract][Full Text] [Related]
7. Targeting the IDO1/TDO2-KYN-AhR Pathway for Cancer Immunotherapy - Challenges and Opportunities.
Cheong JE; Sun L
Trends Pharmacol Sci; 2018 Mar; 39(3):307-325. PubMed ID: 29254698
[TBL] [Abstract][Full Text] [Related]
8. Tryptophan metabolism induced by TDO2 promotes prostatic cancer chemotherapy resistance in a AhR/c-Myc dependent manner.
Li F; Zhao Z; Zhang Z; Zhang Y; Guan W
BMC Cancer; 2021 Oct; 21(1):1112. PubMed ID: 34657603
[TBL] [Abstract][Full Text] [Related]
9. Investigation of the aryl hydrocarbon receptor and the intrinsic tumoral component of the kynurenine pathway of tryptophan metabolism in primary brain tumors.
Guastella AR; Michelhaugh SK; Klinger NV; Fadel HA; Kiousis S; Ali-Fehmi R; Kupsky WJ; Juhász C; Mittal S
J Neurooncol; 2018 Sep; 139(2):239-249. PubMed ID: 29667084
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of the aryl hydrocarbon receptor prevents Western diet-induced obesity. Model for AHR activation by kynurenine via oxidized-LDL, TLR2/4, TGFβ, and IDO1.
Moyer BJ; Rojas IY; Kerley-Hamilton JS; Hazlett HF; Nemani KV; Trask HW; West RJ; Lupien LE; Collins AJ; Ringelberg CS; Gimi B; Kinlaw WB; Tomlinson CR
Toxicol Appl Pharmacol; 2016 Jun; 300():13-24. PubMed ID: 27020609
[TBL] [Abstract][Full Text] [Related]
11. Both IDO1 and TDO contribute to the malignancy of gliomas via the Kyn-AhR-AQP4 signaling pathway.
Du L; Xing Z; Tao B; Li T; Yang D; Li W; Zheng Y; Kuang C; Yang Q
Signal Transduct Target Ther; 2020 Feb; 5(1):10. PubMed ID: 32296044
[TBL] [Abstract][Full Text] [Related]
12. Knockdown of IL4I1 Improved High Glucose-evoked Insulin Resistance in HepG2 Cells by Alleviating Inflammation and Lipotoxicity Through AHR Activation.
Run L; Tian Z; Xu L; Du J; Li N; Wang Q; Sun H
Appl Biochem Biotechnol; 2023 Nov; 195(11):6694-6707. PubMed ID: 36913096
[TBL] [Abstract][Full Text] [Related]
13. Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors activate the aryl hydrocarbon receptor.
Moyer BJ; Rojas IY; Murray IA; Lee S; Hazlett HF; Perdew GH; Tomlinson CR
Toxicol Appl Pharmacol; 2017 May; 323():74-80. PubMed ID: 28336214
[TBL] [Abstract][Full Text] [Related]
14. Aberrant Upregulation of Indoleamine 2,3-Dioxygenase 1 Promotes Proliferation and Metastasis of Hepatocellular Carcinoma Cells via Coordinated Activation of AhR and β-Catenin Signaling.
Chen CT; Wu PH; Hu CC; Nien HC; Wang JT; Sheu JC; Chow LP
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769098
[TBL] [Abstract][Full Text] [Related]
15. Murine Coronavirus Infection Activates the Aryl Hydrocarbon Receptor in an Indoleamine 2,3-Dioxygenase-Independent Manner, Contributing to Cytokine Modulation and Proviral TCDD-Inducible-PARP Expression.
Grunewald ME; Shaban MG; Mackin SR; Fehr AR; Perlman S
J Virol; 2020 Jan; 94(3):. PubMed ID: 31694960
[TBL] [Abstract][Full Text] [Related]
16. IDO1 Expression in Ovarian Cancer Induces PD-1 in T Cells
Amobi-McCloud A; Muthuswamy R; Battaglia S; Yu H; Liu T; Wang J; Putluri V; Singh PK; Qian F; Huang RY; Putluri N; Tsuji T; Lugade AA; Liu S; Odunsi K
Front Immunol; 2021; 12():678999. PubMed ID: 34025677
[TBL] [Abstract][Full Text] [Related]
17. Blockade of IDO-kynurenine-AhR metabolic circuitry abrogates IFN-γ-induced immunologic dormancy of tumor-repopulating cells.
Liu Y; Liang X; Yin X; Lv J; Tang K; Ma J; Ji T; Zhang H; Dong W; Jin X; Chen D; Li Y; Zhang S; Xie HQ; Zhao B; Zhao T; Lu J; Hu ZW; Cao X; Qin FX; Huang B
Nat Commun; 2017 May; 8():15207. PubMed ID: 28488695
[TBL] [Abstract][Full Text] [Related]
18. IL4I1 and tryptophan metabolites enhance AHR signals to facilitate colorectal cancer progression and immunosuppression.
Sun H; Han W; Wen J; Ma X
Am J Transl Res; 2022; 14(11):7758-7770. PubMed ID: 36505324
[TBL] [Abstract][Full Text] [Related]
19. An endogenous tumour-promoting ligand of the human aryl hydrocarbon receptor.
Opitz CA; Litzenburger UM; Sahm F; Ott M; Tritschler I; Trump S; Schumacher T; Jestaedt L; Schrenk D; Weller M; Jugold M; Guillemin GJ; Miller CL; Lutz C; Radlwimmer B; Lehmann I; von Deimling A; Wick W; Platten M
Nature; 2011 Oct; 478(7368):197-203. PubMed ID: 21976023
[TBL] [Abstract][Full Text] [Related]
20. Carboxyamidotriazole combined with IDO1-Kyn-AhR pathway inhibitors profoundly enhances cancer immunotherapy.
Shi J; Chen C; Ju R; Wang Q; Li J; Guo L; Ye C; Zhang D
J Immunother Cancer; 2019 Sep; 7(1):246. PubMed ID: 31511064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]